Nxera Pharma Co., Ltd. (TYO:4565)
Japan · Delayed Price · Currency is JPY 985.00
+14.00 (1.44%)
Jun 24, 2026, 9:33 AM JST
Nxera Pharma Market Cap
Nxera Pharma has a market cap or net worth of 89.93 billion as of June 23, 2026. Its market cap has increased by 13.41% in one year.
Market Cap
89.93B
Enterprise Value
134.16B
Revenue
34.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
985.00
Market Cap Chart
Since July 29, 2004, Nxera Pharma's market cap has increased from 38.40B to 89.93B, an increase of 134.21%. That is a compound annual growth rate of 3.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 89.93B | 20.16% |
| Dec 30, 2025 | 74.84B | -20.57% |
| Dec 30, 2024 | 94.22B | -25.87% |
| Dec 29, 2023 | 127.10B | -27.43% |
| Dec 30, 2022 | 175.15B | 12.85% |
| Dec 30, 2021 | 155.21B | 7.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 141.04B |
| PeptiDream | 123.33B |
| SanBio Company | 79.78B |
| Oncolys BioPharma | 75.89B |
| Healios K.K. | 34.83B |
| Cuorips | 31.87B |
| Japan Tissue Engineering | 25.67B |
| Renascience | 22.18B |